Cargando…

Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ

DNA topoisomerase II (TOP2) is an enzyme that resolves DNA topological problems and plays critical roles in various nuclear processes. Recently, a heterozygous H58Y substitution in the ATPase domain of human TOP2B was identified from patients with autism spectrum disorder, but its biological signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morotomi-Yano, Keiko, Hiromoto, Yukiko, Higaki, Takumi, Yano, Ken-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712534/
https://www.ncbi.nlm.nih.gov/pubmed/36450898
http://dx.doi.org/10.1038/s41598-022-24883-2
_version_ 1784841808815063040
author Morotomi-Yano, Keiko
Hiromoto, Yukiko
Higaki, Takumi
Yano, Ken-ichi
author_facet Morotomi-Yano, Keiko
Hiromoto, Yukiko
Higaki, Takumi
Yano, Ken-ichi
author_sort Morotomi-Yano, Keiko
collection PubMed
description DNA topoisomerase II (TOP2) is an enzyme that resolves DNA topological problems and plays critical roles in various nuclear processes. Recently, a heterozygous H58Y substitution in the ATPase domain of human TOP2B was identified from patients with autism spectrum disorder, but its biological significance remains unclear. In this study, we analyzed the nuclear dynamics of TOP2B with H58Y (TOP2B H58Y). Although wild-type TOP2B was highly mobile in the nucleus of a living cell, the nuclear mobility of TOP2B H58Y was markedly reduced, suggesting that the impact of H58Y manifests as low protein mobility. We found that TOP2B H58Y is insensitive to ICRF-187, a TOP2 inhibitor that halts TOP2 as a closed clamp on DNA. When the ATPase activity of TOP2B was compromised, the nuclear mobility of TOP2B H58Y was restored to wild-type levels, indicating the contribution of the ATPase activity to the low nuclear mobility. Analysis of genome-edited cells harboring TOP2B H58Y showed that TOP2B H58Y retains sensitivity to the TOP2 poison etoposide, implying that TOP2B H58Y can undergo at least a part of its catalytic reactions. Collectively, TOP2 H58Y represents a unique example of the relationship between a disease-associated mutation and perturbed protein dynamics.
format Online
Article
Text
id pubmed-9712534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97125342022-12-02 Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ Morotomi-Yano, Keiko Hiromoto, Yukiko Higaki, Takumi Yano, Ken-ichi Sci Rep Article DNA topoisomerase II (TOP2) is an enzyme that resolves DNA topological problems and plays critical roles in various nuclear processes. Recently, a heterozygous H58Y substitution in the ATPase domain of human TOP2B was identified from patients with autism spectrum disorder, but its biological significance remains unclear. In this study, we analyzed the nuclear dynamics of TOP2B with H58Y (TOP2B H58Y). Although wild-type TOP2B was highly mobile in the nucleus of a living cell, the nuclear mobility of TOP2B H58Y was markedly reduced, suggesting that the impact of H58Y manifests as low protein mobility. We found that TOP2B H58Y is insensitive to ICRF-187, a TOP2 inhibitor that halts TOP2 as a closed clamp on DNA. When the ATPase activity of TOP2B was compromised, the nuclear mobility of TOP2B H58Y was restored to wild-type levels, indicating the contribution of the ATPase activity to the low nuclear mobility. Analysis of genome-edited cells harboring TOP2B H58Y showed that TOP2B H58Y retains sensitivity to the TOP2 poison etoposide, implying that TOP2B H58Y can undergo at least a part of its catalytic reactions. Collectively, TOP2 H58Y represents a unique example of the relationship between a disease-associated mutation and perturbed protein dynamics. Nature Publishing Group UK 2022-11-30 /pmc/articles/PMC9712534/ /pubmed/36450898 http://dx.doi.org/10.1038/s41598-022-24883-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Morotomi-Yano, Keiko
Hiromoto, Yukiko
Higaki, Takumi
Yano, Ken-ichi
Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title_full Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title_fullStr Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title_full_unstemmed Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title_short Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ
title_sort disease-associated h58y mutation affects the nuclear dynamics of human dna topoisomerase iiβ
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712534/
https://www.ncbi.nlm.nih.gov/pubmed/36450898
http://dx.doi.org/10.1038/s41598-022-24883-2
work_keys_str_mv AT morotomiyanokeiko diseaseassociatedh58ymutationaffectsthenucleardynamicsofhumandnatopoisomeraseiib
AT hiromotoyukiko diseaseassociatedh58ymutationaffectsthenucleardynamicsofhumandnatopoisomeraseiib
AT higakitakumi diseaseassociatedh58ymutationaffectsthenucleardynamicsofhumandnatopoisomeraseiib
AT yanokenichi diseaseassociatedh58ymutationaffectsthenucleardynamicsofhumandnatopoisomeraseiib